Clearstead Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,400
Closed -$7.68K 1457
2023
Q1
$7.68K Hold
6,400
﹤0.01% 982
2022
Q4
$9.09K Hold
6,400
﹤0.01% 914
2022
Q3
$16K Sell
6,400
-500
-7% -$1.67K ﹤0.01% 815
2022
Q2
$16K Buy
6,900
+4,400
+176% +$16.4K ﹤0.01% 854
2022
Q1
$17K Buy
2,500
+500
+25% +$4.27K ﹤0.01% 900
2021
Q4
$18K Buy
+2,000
New +$18.6K ﹤0.01% 846
2017
Q4
Sell
-8,858
Closed -$202K 255
2017
Q3
$202K Sell
8,858
-8,858
-50% -$189K 0.03% 241
2017
Q2
$496K Hold
17,716
0.07% 150
2017
Q1
$544K Sell
17,716
-2,000
-10% -$56.5K 0.08% 139
2016
Q4
$496K Buy
+19,716
New +$465K 0.08% 134

Other funds holding DBD

Clearstead Advisors's DBD Position: Q2 2023 in Review

Clearstead Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 6,400 shares — an estimated $7.68K sold.

Clearstead Advisors first reported a position in DBD in Q4 2016 and held it in 10 quarters. The position peaked at $544K in Q1 2017. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Clearstead Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Clearstead Advisors sold 6,400 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $7.68K.
  • Clearstead Advisors first reported a position in Diebold Nixdorf Incorporated in Q4 2016 and held it in 10 quarters.
  • Clearstead Advisors's Diebold Nixdorf Incorporated position peaked at $544K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Clearstead Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.